Lazard Asset Management
BMEZ icon

Lazard Asset Management’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Lazard Asset Management’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.93M Buy
621,604
+243,054
+64% +$3.61M 0.01% 439
2025
Q4 		$5.7M Buy
+378,550
New +$5.68M 0.01% 520
2025
Q2 		– Sell
-597,137
Closed -$8.9M – 2306
2025
Q1 		$8.9M Hold
597,137
– – 0.01% 514
2024
Q4 		$8.6M Sell
597,137
-107,026
-15% -$1.66M 0.01% 500
2024
Q3 		$11.2M Sell
704,163
-94,799
-12% -$1.5M 0.01% 440
2024
Q2 		$12.3M Hold
798,962
– – 0.02% 480
2024
Q1 		$13.1M Buy
798,962
+156,417
+24% +$2.47M 0.02% 469
2023
Q4 		$9.41M Hold
642,545
– – 0.01% 562
2023
Q3 		$9.26M Buy
642,545
+498,079
+345% +$7.77M 0.01% 578
2023
Q2 		$2.37M Hold
144,466
– – ﹤0.01% 858
2023
Q1 		$2.41M Sell
144,466
-20
-0% -$322 ﹤0.01% 875
2022
Q4 		$2.23M Buy
144,486
+306
+0.2% +$4.74K ﹤0.01% 887
2022
Q3 		$2.15M Hold
144,180
– – ﹤0.01% 868
2022
Q2 		$2.37M Buy
+144,180
New +$2.47M ﹤0.01% 869

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Lazard Asset Management's BMEZ Position: Q1 2026 in Review

Lazard Asset Management increased its BlackRock Health Sciences Trust II (BMEZ) stake by 64% in Q1 2026, buying an estimated $3.61M and bringing the position to 621,604 shares worth $8.93M. The position accounts for 0.01% of the portfolio, ranked #439.

Lazard Asset Management first reported a position in BMEZ in Q2 2022 and has held it in 14 quarters since. The position peaked at $13.1M in Q1 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q1 2026.

  • Lazard Asset Management held 621,604 shares of BlackRock Health Sciences Trust II worth $8.93M as of Q1 2026.
  • Lazard Asset Management bought 243,054 BlackRock Health Sciences Trust II shares in Q1 2026, an estimated $3.61M.
  • BlackRock Health Sciences Trust II made up 0.01% of Lazard Asset Management's portfolio in Q1 2026, its #439 holding.
  • Lazard Asset Management first reported a position in BlackRock Health Sciences Trust II in Q2 2022 and has held it in 14 quarters since.
  • Lazard Asset Management's BlackRock Health Sciences Trust II position peaked at $13.1M in Q1 2024.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.